REDENTI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 1.914
EU - Europa 1.452
AS - Asia 905
SA - Sud America 115
Continente sconosciuto - Info sul continente non disponibili 101
AF - Africa 57
OC - Oceania 4
Totale 4.548
Nazione #
US - Stati Uniti d'America 1.863
PL - Polonia 353
IT - Italia 327
SG - Singapore 285
SE - Svezia 209
CN - Cina 202
DE - Germania 106
BR - Brasile 90
FR - Francia 77
GB - Regno Unito 76
NL - Olanda 70
IN - India 64
VN - Vietnam 63
HK - Hong Kong 62
BD - Bangladesh 55
KR - Corea 49
UA - Ucraina 48
FI - Finlandia 46
RU - Federazione Russa 44
TR - Turchia 36
CA - Canada 28
EG - Egitto 23
BG - Bulgaria 20
IE - Irlanda 17
PK - Pakistan 17
CZ - Repubblica Ceca 14
JP - Giappone 13
BE - Belgio 10
AR - Argentina 9
AT - Austria 8
CO - Colombia 8
IQ - Iraq 8
ID - Indonesia 7
ES - Italia 6
MA - Marocco 6
TT - Trinidad e Tobago 6
PH - Filippine 5
TH - Thailandia 5
TW - Taiwan 5
UZ - Uzbekistan 5
BB - Barbados 4
DZ - Algeria 4
EU - Europa 4
IR - Iran 4
KE - Kenya 4
MX - Messico 4
SA - Arabia Saudita 4
AU - Australia 3
CI - Costa d'Avorio 3
EC - Ecuador 3
ET - Etiopia 3
LT - Lituania 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
CH - Svizzera 2
EE - Estonia 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
KZ - Kazakistan 2
LU - Lussemburgo 2
PE - Perù 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
AO - Angola 1
AW - Aruba 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GD - Grenada 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KY - Cayman, isole 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
MG - Madagascar 1
MN - Mongolia 1
MV - Maldive 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
TG - Togo 1
VE - Venezuela 1
ZM - Zambia 1
Totale 4.451
Città #
Dallas 349
Warsaw 338
Ashburn 171
Singapore 171
Fairfield 103
Houston 101
Chandler 99
Trieste 96
Woodbridge 92
Ann Arbor 87
San Jose 80
Hefei 78
Cambridge 59
Hong Kong 56
Wilmington 55
Seoul 47
Seattle 46
Munich 45
Beijing 44
Jacksonville 44
Columbus 38
Amsterdam 32
The Dalles 27
Princeton 25
Boardman 23
Milan 23
Cairo 22
Los Angeles 22
Council Bluffs 20
Sofia 20
Izmir 18
London 18
Dublin 17
New York 17
Santa Clara 17
Helsinki 16
Mestre 16
Buffalo 15
Chicago 15
Frankfurt am Main 15
Istanbul 15
Turku 14
Hanoi 13
Ho Chi Minh City 13
North Bergen 13
Rome 13
Brno 12
Chennai 11
Düsseldorf 11
Lauterbourg 11
Moscow 11
Tokyo 11
Zgierz 11
Shanghai 10
Guangzhou 9
Toronto 8
Udine 8
Dhaka 7
Redwood City 7
Verona 7
Falls Church 6
Indore 6
Kanpur 6
Nanchang 6
Nashville 6
Phoenix 6
Sacile 6
São Paulo 6
Torre Del Greco 6
West Jordan 6
Brooklyn 5
Brussels 5
Orem 5
Poplar 5
San Francisco 5
Spinea 5
Tashkent 5
Vienna 5
Bremen 4
Bridgetown 4
Cagliari 4
Casablanca 4
Dong Ket 4
Lahore 4
Manchester 4
Medellín 4
Nairobi 4
New Delhi 4
Padova 4
Philadelphia 4
Pittsburgh 4
Redondo Beach 4
Urbino 4
Abidjan 3
Atlanta 3
Bologna 3
Boston 3
Campinas 3
Citta 3
Codroipo 3
Totale 2.973
Nome #
[1,2,4]triazolo[1,5-c]pyrimidines as A(3) adenosine receptor antagonists 673
DESIGN, SYNTHESIS AND CHARACTERIZATION OF GSK-3β AND CK-1δ INHIBITORS 534
The Influence of the 1-(3-Trifluoromethyl-Benzyl)-1H-Pyrazole-4-yl Moiety on the Adenosine Receptors Affinity Profile of Pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c]Pyrimidine Derivatives 445
A Triazolotriazine-Based Dual GSK-3β/CK-1δ Ligand as a Potential Neuroprotective Agent Presenting Two Different Mechanisms of Enzymatic Inhibition 414
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and Structurally Simplified Analogs. Chemistry and SAR Profile as Adenosine Receptor Antagonists 361
5,7-Disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazines as pharmacological tools to explore the antagonist selectivity profiles toward adenosine receptors 304
Scaffold decoration at positions 5 and 8 of 1,2,4-triazolo[1,5- c ]pyrimidines to explore the antagonist profiling on adenosine receptors: A preliminary structure-activity relationship study 293
Mixed-reversible and covalent kinase inhibition as a possible new strategy to treat neuro-inflammatory/degenerative diseases 253
N8-Isopentyl and N8-Phenylethyl Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine Derivatives as Adenosine Receptor Antagonists 252
null 245
Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems 231
Conjugable A3 Adenosine Receptor Antagonists: Probing the 5 Position of the Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine Scaffold. 183
CVT 6975-like Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine Derivatives: an Attempt towards A2B Adenosine Receptor Affinity. 174
null 97
null 89
Totale 4.548
Categoria #
all - tutte 10.177
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.177


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022228 0 0 17 73 11 10 7 8 31 30 5 36
2022/2023295 29 44 21 51 26 51 0 21 36 7 9 0
2023/2024255 10 16 19 13 18 29 62 44 3 14 12 15
2024/2025585 32 25 63 52 42 34 35 24 61 85 47 85
2025/20261.467 171 168 347 92 74 68 140 35 105 133 57 77
2026/2027123 32 49 42 0 0 0 0 0 0 0 0 0
Totale 4.548